|
|
||||||||
Department of Pediatrics, University of Iowa, Iowa City
Address reprint requests to: Ekhard E. Ziegler, MD, Department of Pediatrics, University of Iowa, 200 Hawkins Drive, Iowa City, Iowa 52242-1083
| ABSTRACT |
|---|
|
|
|---|
Methods: Formula PO contained palm olein (45%) in addition to soy, coconut and high-oleic sunflower oils (20%, 20%, and 15%, respectively); Formula HOS contained high-oleic safflower oil (42%) in addition to coconut and soy oils (30% and 28%, respectively) and no palm olein. Fat and calcium levels in the two formulas were similar. In a balanced crossover design, fat and calcium absorption were determined in 10 normal infants ranging in age from 22 to 192 days. In three infants metabolic balance studies with complete separation of urine and feces were performed, whereas in seven infants excreta were in part collected at home, resulting in incomplete separation of urine and feces.
Results: Mean (±SD) fecal excretion of fat was higher when Formula PO was fed than when Formula HOS was fed (0.55±0.29 vs. 0.09±0.04 g/kg/day; p<0.001). Hence % fat absorption was lower with PO than with HOS (90.0±6.4 vs. 98.5±0.6% of intake; p<0.01). The difference in percent fat absorption was explained by significantly (p<0.05) lower % absorption of palmitic (16:0) and stearic (18:0) acids when Formula PO was fed than when Formula HOS was fed. Fecal excretion of calcium was higher with Formula PO than with Formula HOS (53.4±12.0 vs. 37.4±14.9 mg/kg/day; p<0.01), and hence % calcium absorption was lower with Formula PO than with Formula HOS (37.5±11.5 vs. 57.4±14.9%; p<0.001).
Conclusion: Absorption of fat and calcium by normal infants is lower when palm olein provides a substantial proportion of formula fat than when formula does not contain palm olein.
Key words: Palm olein, infant formula, fat absorption, calcium absorption
| INTRODUCTION |
|---|
|
|
|---|
Palm olein, a lower-melting fraction of palm oil, contains 40% palmitic acid and 43% oleic acid. It is used in some commercially available infant formulas. In a previous study [8] we found that when palm olein provided the major proportion (53%) of the fat blend of a milk-based infant formula, with soy oil providing the remainder (47%), fat and calcium absorption were significantly lower than from a milk-based formula containing coconut oil (40%) and soy oil (60%). The lower overall fat absorption was nearly quantitatively explained by poor absorption of palmitic acid from the palm olein-containing formula. Lower calcium absorption was presumed to be secondary to formation of insoluble calcium soaps.
In our previous study [8] the two fat blends differed greatly in fatty acid composition. For example, the formula with coconut and soy oils provided 18% of fatty acids from lauric acid (C12:0) and an additional 5.9% from shorter chain fatty acids (C6:0-C10:0), whereas the palm olein-containing formula provided only 0.2% of fatty acids from lauric acid and no shorter-chain fatty acids. It remained unclear whether the inclusion of palm olein would also cause a reduction of overall fat absorption when compared to a fat blend with similar proportions of medium chain-length fatty acids. The present study was undertaken to answer this question. We tested the hypothesis that inclusion of palm olein (45% of fat) in the fat blend leads to a decrease of fat and calcium absorption compared to a blend without palm olein but of otherwise similar fatty acid composition. The palm olein-containing formula provided more palmitic acid (22.1% of fatty acids) than the control formula (8.2% of fatty acids), but the fatty acid profiles were otherwise similar. The study showed that inclusion of palm olein caused a decrease in absorption of fat and calcium of a magnitude similar to that observed in the previous study [8].
| MATERIALS AND METHODS |
|---|
|
|
|---|
Subjects
Ten infants (four females and six males) participated in the study. All were singletons. Eight infants were born at term (gestation 39 to 40 weeks) with birth weights between 3545 and 4850 g. One infant was born at 37 weeks of gestation weighing 2665 g and one at 34 weeks weighing 2975 g. At the start of the first study, nine infants were between 22 and 91 days old and one infant was 192 days old. Infants lived at home between studies. The study protocol was approved by the University of Iowa Committee on Research Involving Human Subjects and one or both parents provided written informed consent.
Feedings
The two study formulas were similar in composition except for the source of fat (Table 1). One formula (Formula PO) provided fat from a blend of palm olein (45%), soy oil (20%), coconut oil (20%) and high-oleic sunflower oil (15%). The other formula (Formula HOS) contained a blend of high-oleic safflower oil (42%), coconut oil (30%) and soy oil (28%). The fatty acid profiles are included in Table 1, along with the typical profile of breast milk. Both formulas contained oleic acid in a proportion similar to human milk; palmitic acid was lower in Formula HOS than in human milk. The protein of both formulas was derived from cow milk with added bovine whey proteins, and the carbohydrate was lactose. Both formulas contained the customary amounts of vitamins and trace minerals believed to satisfy the needs of normal infants. Formula HOS contained added nucleotides. The formulas were supplied in ready-to-feed form in 32-oz. cans labeled only by code. Formula PO was Enfamil® (Mead Johnson Nutritional Group, Evansville, IN) as marketed at the time of purchase (1993), and Formula HOS was similar to the formula subsequently marketed as Improved Similac® with Iron (Ross Products Division, Columbus, OH).
|
Methods
Stools collected during the 72 hour metabolic balance studies were pooled for each subject. They were homogenized by vigorous stirring and aliquots saved for analyses of fat and calcium. In home collections, fecal matter was scraped from the diapers, added to the fecal pool from the daytime collection, and homogenized. Diapers were then eluted with nitric acid followed by fat extraction with hot ethanol as described [8]. Total fat was determined by the method of Van de Kamer et al [11], fatty acids (from fecal material of 9 of the 10 study infants) were derivatized by the method of Metcalfe and Schmitz [12] and separated by gas-liquid chromatography. Fecal calcium was determined by atomic absorption spectrophotometry.
Data Analysis
Absorption (net) of nutrients was calculated as intake minus fecal excretion. Intakes of fat and calcium were calculated from the weight of formula consumed, multiplied by the respective fat and calcium concentrations. In studies with home collections, fecal fat was calculated as the sum of fat in the solid fecal matter plus fat in the ethanol extract, and fecal calcium was calculated as the sum of calcium in the solid fecal matter plus calcium in the eluate plus calcium in the ethanol extract. The absorption of individual fatty acids was calculated as fatty acid intake [formula fat intakex0.95xformula fatty acid wt%/100] minus fecal fatty acid excretion [fecal fatxfecal fatty acid wt%/100]. The 0.95 reflects the fatty acid proportion in a typical triacylglycerol.
Data on absorption and excretion were analyzed by repeated measures analysis of variance. Data obtained by the 72-hour metabolic balance studies were combined with those obtained by 96-hour home collections after preliminary analysis demonstrated the absence of effects of the collection method on absorption data. Data were also tested for carryover effects (at p<0.10) and for order effects (at p<0.05) using a crossover analysis with two-sample t-tests. No carryover or order effects were detected. Partial correlations between fecal calcium and fecal fat, palmitic (16:0) or stearic (18:0) acid were determined by general linear models procedures with adjustment for the effect of formula.
| RESULTS |
|---|
|
|
|---|
Intake, fecal excretion and absorption of total fat and of selected fatty acids are summarized in Table 2. Total fat intake was not different, but, as expected, intake of palmitic acid from Formula PO was about three times that from Formula HOS. Intakes of other fatty acids were similar. Fecal excretion of total fat averaged 0.55 g/kg/day when Formula PO was fed, but averaged only 0.09 g/kg/day when Formula HOS was fed. The difference was statistically significant (p<0.001) and remained so (p<0.001) after exclusion of data from Subject #6451. Mean fecal fat excretions after excluding Subject #6451 were 0.46 and 0.09 g/kg/day, respectively, with Formula PO and Formula HOS. Fecal excretion of palmitic acid averaged 0.34 g/kg/day with Formula PO and 0.04 g/kg/day with Formula HOS. The difference was statistically significant (p<0.01). More than half the excess fecal fat with Formula PO was accounted for by palmitic acid. Fecal excretion of stearic acid was also significantly (p<0.01) higher with Formula PO, but, because stearic acid contributed only 4.7% of the fatty acid intake from Formula PO, the contribution of stearic acid to total fecal fat was much smaller than that of palmitic acid.
|
|
Intake, excretion, and absorption of calcium are summarized in Table 3. Intakes were similar with the two formulas. However, fecal excretion of calcium was substantially (p=0.002) higher with Formula PO than with Formula HOS. Consequently, calcium absorption, whether expressed as mg/kg/day or as percent of intake, was significantly (p<0.001) lower from Formula PO than from Formula HOS. Exclusion of data of Subject #6451 changed the mean values somewhat, but the differences remained significant. As indicated in Fig. 2, a decrease in percent calcium absorption was observed in every infant when fed Formula PO. Fecal excretion of calcium was significantly correlated with excretion of total fat (r=0.649, p<0.01) and of palmitic acid (r=0.585; p<0.02), but not stearic acid (r=0.259; p=0.33).
|
|
| DISCUSSION |
|---|
|
|
|---|
Palmitic acid accounted for a large proportion of unabsorbed (fecal) fat in both the previous and the present study. In palm oil, only about 9% of the palmitic acid is located in the sn-2 position [3,13], and hence almost all the palmitic acid is present in the sn-1 and sn-3 positions. It is generally agreed that pancreatic lipase liberates preferentially fatty acids esterified in the sn-1 and sn-3 positions, sparing fatty acids in the sn-2 position. The resulting 2-mono-acyl-glycerol is well absorbed regardless of the chain length and/or degree of saturation of the fatty acid. There is good evidence that it is absorbed intact [14]. The excellent absorption of human milk fat [15], despite its high content of palmitic acid (22% of fatty acids), is generally attributed to the fact that 70% of the palmitic acid in human milk fat is present in the sn-2 position [1,2]. On the other hand, the efficiency of absorption of free fatty acids liberated from the sn-1 and sn-3 positions depends on the nature of the fatty acids. Long-chain saturated fatty acids, such as palmitic and stearic acids, are poorly absorbed and are prone to the formation of insoluble soaps with calcium and magnesium. In the present study, absorption of palmitic acid from Formula PO averaged 70.5% and that of stearic acid averaged 63.6%. Together, these two fatty acids accounted for about 80% of the excess fecal fat excreted by infants fed Formula PO.
The present study also confirmed that absorption of calcium is lower when palm olein is present than when it is absent from a milk-based formula. The fact that fecal excretion of calcium was correlated with fecal excretion of palmitic acid and total fat reinforces the interpretation that the formation of insoluble soaps occurs when saturated fatty acids are liberated in the presence of calcium.
Because the present study utilized a balanced crossover design in which each infant served as his/her own control, neither the inclusion of two premature infants nor the wide subject age range affected the interpretability of results. Moreover, there was no detectable trend toward an age effect on fat or calcium absorption. With regard to gestational age, only absorption of calcium, not fat, showed a trend toward higher percent absorption in the two premature infants, an observation that had been noted in our previous study [8].
The clinical relevance of the findings of the present study remains uncertain. Quinlan et al [16] demonstrated that stool hardness is a function of the concentration of calcium soaps of saturated fatty acids. Stool consistency was not determined in the present study, but it appears possible that palm olein in an infant formula may lead to harder stools. Somewhat increased fecal loss of dietary fat and hence energy was associated with feeding of palm olein-containing formula. As we have stated before [8], it is quite likely that infants are able to compensate for the modest loss of energy by consuming more formula. Similarly, the clinical importance of decreased absorption of calcium cannot be assessed from our short-term metabolic balance studies. Long-term effects, e.g., on bone mineral content, although theoretically possible, are not likely to occur since several other factors, besides percentage calcium absorption, interact to determine bone mineral content over the long term.
| ACKNOWLEDGMENTS |
|---|
Received October 1, 1997. Accepted December 1, 1997.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. W.K. Koo, E. M. Hockman, and M. Dow Palm olein in the fat blend of infant formulas: effect on the intestinal absorption of calcium and fat, and bone mineralization. J. Am. Coll. Nutr., April 1, 2006; 25(2): 117 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Abrams and S. A. Atkinson Calcium, Magnesium, Phosphorus and Vitamin D Fortification of Complementary Foods J. Nutr., September 1, 2003; 133(9): 2994S - 2999. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. K. Koo, M. Hammami, D. P. Margeson, C. Nwaesei, M. B. Montalto, and J. B. Lasekan Reduced Bone Mineralization in Infants Fed Palm Olein-Containing Formula: A Randomized, Double-Blinded, Prospective Trial Pediatrics, May 1, 2003; 111(5): 1017 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. K. Koo Efficacy and Safety of Docosahexaenoic Acid and Arachidonic Acid Addition to Infant Formulas: Can One Buy Better Vision and Intelligence? J. Am. Coll. Nutr., April 1, 2003; 22(2): 101 - 107. [Abstract] [Full Text] |
||||
![]() |
K. M Ostrom, M. W Borschel, J. E Westcott, K. S Richardson, and N. F Krebs Lower Calcium Absorption in Infants Fed Casein Hydrolysate- and Soy Protein-Based Infant Formulas Containing Palm Olein Versus Formulas without Palm Olein J. Am. Coll. Nutr., December 1, 2002; 21(6): 564 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A Abrams, I. J Griffin, and P. M Davila Calcium and zinc absorption from lactose-containing and lactose-free infant formulas Am. J. Clinical Nutrition, August 1, 2002; 76(2): 442 - 446. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |